On Feb. 12, 2016, it was announced that Mets pitcher Jenrry Mejia would be face a permanent suspension under Major League Baseball's Joint Drug Prevention and Treatment Program after his third positive drug test for performance-enhancing drugs, this one for the anabolic steroid Boldenone.
Mejia's first failed test and the subsequent 80-game suspension for testing positive for Stanozolol were announced on April 11, 2015. On July 28, 2015, while Mejia was serving the 80-game suspension, it was announced that he tested positive for Stanozolol and Boldenone and he would face a 162-game suspension.
Despite becoming the first player in MLB history to be given a lifetime ban for repeated PED—a rule that was instituted in 2013—Mejia will have a chance to get back to the majors, as it was announced Friday that he was granted conditional reinstatement.